Introduction
Zimiplan DSR by Astemax Biotech is an advanced sustained-release capsule combining pantoprazole gastro-resistant pellets with domperidone prolonged-release pellets, offering 24-hour relief from acid reflux and digestive discomfort. This dual-action formula ensures superior efficacy through optimized release technology, produced in WHO-GMP certified facilities for uncompromising quality and ethical standards.
Product Highlights
Zimiplan DSR features pantoprazole 40 mg for potent acid suppression and domperidone 30 mg for enhanced gastric motility in a single, once-daily capsule. The sustained-release design delivers steady therapeutic levels, minimizing fluctuations for better patient outcomes. Ideal for modern lifestyles demanding reliable GI support.
Key Benefits
Rapidly neutralizes heartburn, GERD symptoms, and acid regurgitation with prolonged action.
Boosts stomach emptying to reduce bloating, nausea, and indigestion effectively.
Prevents ulcer recurrence and supports healing of erosive esophagitis through dual synergy.
Quality Standards
Crafted in Astemax’s WHO-GMP certified plants, Zimiplan DSR undergoes rigorous testing for purity, stability, and bioavailability. Ethical marketing focuses on evidence-based claims, prioritizing physician trust and patient safety without hype.
How It Works
Pantoprazole irreversibly blocks proton pumps to cut acid production by over 90%, while domperidone stimulates peristalsis for faster digestion. The prolonged formula ensures intestinal release of pantoprazole and sustained domperidone activity for all-day efficiency.
